Peak Uptake of 111In-ABT-806i in Target Tumor Lesion in Cohort 2 Patients, Calculated from SPECT/CT Images
| Infusion 111In-ABT-806i (tumor maximal uptake [%ID]) | |||
| Subject | Site of reference lesion | First | Second |
| 7 | Right hilum | 1.290% | 1.321% |
| 8 | Right pharyngeal | 0.078% | 0.092% |
| 9 | Left lung | 0.043% | 0.041% |
| 10 | Right peritoneum | 0.265% | 0.264% |
| 11 | Subcarinal node | N/A | N/A |
| 12 | Right lung | 0.038% | 0.037% |
| 13 | Hypopharynx | 0.030% | 0.024% |
| 14 | Right hilum | 0.067% | 0.057% |
| 15 | Right lung | 0.064% | 0.087% |
| 16 | Left lung | 0.050% | 0.051% |
| 17 | Right lung | 5.837% | 6.679% |
| 18 | Left lung | 0.009% | 0.009% |
N/A = target lesion not assessable for quantitative dosimetry.